<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05056103</url>
  </required_header>
  <id_info>
    <org_study_id>TrachFlush</org_study_id>
    <nct_id>NCT05056103</nct_id>
  </id_info>
  <brief_title>Automated Secretion Removal in ICU Patients</brief_title>
  <acronym>TrachFlush</acronym>
  <official_title>Effect of an Automated Secretion Removal Technology, Named TrachFlush, on the Need for Tracheal Suctioning - Protocol for a Study in Intubated and Mechanically Ventilated Intensive Care Unit Patients</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      SUMMARY Rationale In intubated and mechanically ventilated critically ill patients, removal&#xD;
      of airway secretions is typically performed by tracheal suctioning, an intervention that is&#xD;
      labor-intensive and very unpleasant for the patient. The current study tests the hypothesis&#xD;
      that a novel secretion removal technology named TrachFlush, that pushes airway secretions&#xD;
      past and above the cuff of the endotracheal tube, reduces the need for tracheal suctioning.&#xD;
&#xD;
      Objective The primary objective of this study is to evaluate whether use of the TrachFlush&#xD;
      reduces the need for tracheal suctioning. In a selection of patients, one secondary objective&#xD;
      is to ascertain the exact volume of airway secretions that is pushed past and above the cuff&#xD;
      of the endotracheal tube.&#xD;
&#xD;
      Study design Open prospective intervention study. Study population One hundred adult,&#xD;
      intubated and mechanically ventilated ICU patients expected to need invasive ventilation &gt; 24&#xD;
      hours.&#xD;
&#xD;
      Intervention The attending nurses activate the TrachFlush when there are secretions present&#xD;
      in the larger airways that need to be removed. If this results into a push of airway&#xD;
      secretions past and above the cuff of the endotracheal tube, no further action is needed. If&#xD;
      unsuccessful, the nurse will perform a standard tracheal suctioning procedure to remove the&#xD;
      secretions. In a subset of patients with an endotracheal tube that allows subglottal&#xD;
      suctioning, the exact amount of airway secretions present above the cuff will be measured&#xD;
      each time the TrachFlush is used.&#xD;
&#xD;
      Main study parameters/endpoints The proportion of successful TrachFlush activations from&#xD;
      start of the study to complete weaning from the ventilator, or a maximum of 7 days (primary).&#xD;
      Secondary endpoints include the total number of TrachFlush activations during the same time&#xD;
      window (all patients), and the exact amount of airway secretions pushed past and above the&#xD;
      cuff of the endotracheal tube (in patients with a tube allows subglottal suctioning).&#xD;
&#xD;
      Nature and extent of the burden and risks associated with participation, benefit and group&#xD;
      relatedness Inappropriate deflation or inflation of the endotracheal cuff by the TrachFlush&#xD;
      could cause harm. However, the cuff pressure will be checked regularly, and if necessary&#xD;
      corrected, at least every time the TrachFlush has been used. Patients may benefit from the&#xD;
      intervention, as the need for tracheal suctioning may reduce.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">September 15, 2021</start_date>
  <completion_date type="Anticipated">March 1, 2022</completion_date>
  <primary_completion_date type="Anticipated">December 31, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>proportion of successful TrachFlush activations from start of the study to complete weaning from the ventilator, or a maximum of 7 days</measure>
    <time_frame>7 days</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>total number of TrachFlush activations during the same time window (all patients)</measure>
    <time_frame>7 days</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>incidence of hypoxemia related to the TrachFlush activation or tracheal suction</measure>
    <time_frame>7 days</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Incidence of hypotension related to the TrachFlush activation or tracheal suction</measure>
    <time_frame>7 days</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Incidence of patient agitation related to the TrachFlush activation or tracheal suctions</measure>
    <time_frame>7 days</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>The volume of subglottal secretions with each TrachFlush intervention (in a patients with an endotracheal tube in place that allows subglottic suctioning).</measure>
    <time_frame>7days</time_frame>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Mechanical Ventilation Complication</condition>
  <arm_group>
    <arm_group_label>TrachFlush</arm_group_label>
    <arm_group_type>Other</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>TrachFlush</intervention_name>
    <description>The attending nurses activate the TrachFlush when there are secretions present in the larger airways that need to be removed. If this results into a push of airway secretions past and above the cuff of the endotracheal tube, no further action is needed. If unsuccessful, the nurse will perform a standard tracheal suctioning procedure to remove the secretions. In a subset of patients with an endotracheal tube that allows subglottal suctioning, the exact amount of airway secretions present above the cuff will be measured each time the TrachFlush is used.</description>
    <arm_group_label>TrachFlush</arm_group_label>
    <other_name>endotracheal suctioning</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  admission to one of the participating ICUs;&#xD;
&#xD;
          -  intubated with an endotracheal tube containing a cuff;&#xD;
&#xD;
          -  receiving invasive mechanical ventilation; and&#xD;
&#xD;
          -  expected to need invasive ventilation beyond the following calendar day at the moment&#xD;
             of inclusion.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  age &lt; 18 years;&#xD;
&#xD;
          -  known or suspected tracheal damage, e.g., after inhalation trauma, thorax trauma, or&#xD;
             intubation trauma;&#xD;
&#xD;
          -  any condition for which deflation of the endotracheal cuff is deemed detrimental,&#xD;
             e.g., in case high airway pressures are needed; and&#xD;
&#xD;
          -  any infection, or colonization with pathogens that require strict single isolation of&#xD;
             the patient (cohort isolation is allowed).&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Frederique Paulus, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>AIDS Malignancy Consortium</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Frederique Paulus, PhD</last_name>
    <phone>020 566 9111</phone>
    <email>f.paulus@amsterdamumc.nl</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Christel Valk, MD</last_name>
    <phone>020 566 9111</phone>
    <email>c.m.valk@amsterdamumc.nl</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Amsterdam UMC</name>
      <address>
        <city>Amsterdam</city>
        <zip>1105AZ</zip>
        <country>Netherlands</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Frederique Paulus, PhD</last_name>
      <phone>020 566 9111</phone>
      <email>f.paulus@amsterdamumc.nl</email>
    </contact>
  </location>
  <location_countries>
    <country>Netherlands</country>
  </location_countries>
  <verification_date>September 2021</verification_date>
  <study_first_submitted>September 15, 2021</study_first_submitted>
  <study_first_submitted_qc>September 15, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">September 24, 2021</study_first_posted>
  <last_update_submitted>September 15, 2021</last_update_submitted>
  <last_update_submitted_qc>September 15, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">September 24, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)</investigator_affiliation>
    <investigator_full_name>Prof. Dr. Marcus J. Schultz</investigator_full_name>
    <investigator_title>Prof.</investigator_title>
  </responsible_party>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

